SNT 0.00% 3.5¢ syntara limited

Ann: Pharmaxis Submits IND Application for Myelofibrosis, page-2

  1. 27 Posts.
    I'd like to know where the money for these planned studies will come from? without a sale of LOLX2 which they have been looking for a buyer since early 2019, cash will be running very low by the end of the year. I guess they have the 10mill coming once FDA finally approve Bronchitol in US. fingers crossed LOLX2 gets a partner soon.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.5¢
Change
0.000(0.00%)
Mkt cap ! $45.16M
Open High Low Value Volume
3.6¢ 3.6¢ 3.3¢ $58.54K 1.668M

Buyers (Bids)

No. Vol. Price($)
1 5226 3.5¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 969288 2
View Market Depth
Last trade - 16.10pm 27/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.